Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic Melanoma
Francesca Aroldi, Mark R. Middleton
Topics & Concepts
IpilimumabNivolumabMedicinePembrolizumabMelanomaMetastatic melanomaOncologyImmunotherapyClinical trialInternal medicineImmunologyCancerCancer researchCancer Immunotherapy and BiomarkersCAR-T cell therapy researchMelanoma and MAPK Pathways